Supplemental Figure S3 from Targeting the RXR Pathway for the Prevention of Triple-Negative Breast Cancer
Abstract
Supplemental Figure S3: Effect of RXR agonists on body weight and blood parameters from the first Brca1-deficient experiment
Fields of Study & Subjects
Estrogen and related hormone effects
Breast Cancer Treatment Studies
Peroxisome Proliferator-Activated Receptors
Publication details
- Publication date
- 3 March 2026
- Language
- EN